Page last updated: 2024-10-31

entinostat and Pulmonary Disease, Chronic Obstructive

entinostat has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies

Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.

Research Excerpts

ExcerptRelevanceReference
"Chronic obstructive pulmonary disease (COPD) constitutes a major health burden."1.46HDAC1-3 inhibitor MS-275 enhances IL10 expression in RAW264.7 macrophages and reduces cigarette smoke-induced airway inflammation in mice. ( Bischoff, R; Bos, S; Dekker, FJ; Eleftheriadis, N; Gjaltema, RA; Gosens, R; Haisma, HJ; Kistemaker, LE; Krist, K; Leus, NG; Mekonnen, SA; Ourailidou, ME; van den Bosch, T; van der Wouden, PE, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leus, NG1
van den Bosch, T1
van der Wouden, PE1
Krist, K1
Ourailidou, ME1
Eleftheriadis, N1
Kistemaker, LE1
Bos, S1
Gjaltema, RA1
Mekonnen, SA1
Bischoff, R1
Gosens, R1
Haisma, HJ1
Dekker, FJ1

Other Studies

1 other study available for entinostat and Pulmonary Disease, Chronic Obstructive

ArticleYear
HDAC1-3 inhibitor MS-275 enhances IL10 expression in RAW264.7 macrophages and reduces cigarette smoke-induced airway inflammation in mice.
    Scientific reports, 2017, 03-27, Volume: 7

    Topics: Animals; Anti-Inflammatory Agents; Benzamides; Cell Line; Histone Deacetylase Inhibitors; Interleuki

2017